Stock NGNE NEUROGENE INC.
Add to a list
To use this feature you must be a member
Log inSign up

Official Publications Neurogene Inc.

Equities

NGNE

US64135M1053

Market Closed - Nasdaq
Other stock markets
 04:00:00 2024-05-20 pm EDT 		5-day change 1st Jan Change
34.01 USD +2.10% Intraday chart for Neurogene Inc. +11.00% +75.49%
May. 10 Neurogene Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
May. 07 Neurogene Presents Favorable Safety Data from Phase 1/2 Trial of Ngn-401 Gene Therapy for Rett Syndrome During Asgct Annual Meeting CI

Official Publications

No official publication found

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies
  1. Stock Market
  2. Equities
  3. NGNE Stock
  4. News Neurogene Inc.
  5. Official Publications
-40% Exceptional extension: Our subscriptions help you unlock the best investment opportunities.
BENEFIT NOW